MDXH

MDxHealth SA Ordinary Shares (MDXH)

Stock · NASDAQ · Health Care

$0.2066as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

MDXH Included in Weekly Health Care Stock Movers List. MDxHealth shares were listed among twelve health care stocks showing movement in Wednesday's intraday session. The stock is currently trading near its 52-week low, with an average analyst target of $1.80. This inclusion highlights recent price action within the broader healthcare sector.

Active signals

Resistance level
$0.42325
Industry
Medical Specialities

What MDXH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike40-4.2%43%
Bollinger Band Breakdown20-4.7%45%
Bollinger Band Breakout18-4.0%44%
200-Day Moving Average TouchActive now9-4.8%33%
Any 20-session window (baseline)-4.1%41%

Computed by MarketWall from daily closing prices since August 22, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About MDXH

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having c…

Sector
Health Care
Industry
Medical Specialities
Employees
364

Fundamentals

1-day range
$0.576$0.6499
Market cap
$22.50M
P/E (trailing)
—
P/E (forward)
-1.59
EPS (trailing)
$-0.89
Dividend yield
—
Beta
0.74
Avg. volume
5.76M
52-week range
$0.4$5.33
Next earnings: November 12, 2026 · EPS estimate $-0.11confirmed

Forecasts

5 analyst ratings

Buy 75%
Hold 25%
Sell 0%
1-year price forecast
High
$3
+1352.1%
Median
$2
+868.1%
Low
$1
+384.0%

MDxHealth SA Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • MDXH
    MDxHealth SA Ordinary Shares
    $0.207
    ▼ 65.73%
    Market cap $22.50MP/E —
    $0.4$5.33
  • YDESW
    YD Bio Limited Warrants
    $0.599
    ▼ 9.24%
    Market cap $16.29MP/E —
    $0.1904$2.5
  • ADVB
    Advanced Biomed Inc. Common Stock
    $3.98
    ▼ 18.44%
    Market cap $12.29MP/E 1.53
    $3.61$24.23
  • AMS
    American Shared Hospital Services Common Stock
    $1.28
    ▲ 1.59%
    Market cap $9.67MP/E —
    $1.21$2.39
  • ACON
    Aclarion Inc. Common Stock
    $1.85
    ▼ 5.27%
    Market cap $5.79MP/E —
    $1.89$9.38
  • BGLC
    BioNexus Gene Lab Corp Common stock
    $1.2
    ▼ 1.64%
    Market cap $3.82MP/E —
    $1.07$5.89
  • SERA
    Sera Prognostics Inc. Class A Common Stock
    $2.06
    ▲ 1.48%
    Market cap $78.32MP/E —
    $1.56$3.95

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
3.86M
Disposed
0
  • MVM Partners, LLC · August 13, 2026 · Buy
    2.20M @ $0.454
  • HARDISON DON M · June 1, 2026 · Grant
    10.0K
  • Sollee Joseph · June 1, 2026 · Grant
    154.1K
  • Sollee Joseph · June 1, 2026 · Grant
    83.0K
  • OConnell Brendan · June 1, 2026 · Grant
    65.0K
  • OConnell Brendan · June 1, 2026 · Grant
    35.0K
  • Windels Hilde · June 1, 2026 · Grant
    10.0K
  • Siegel Sanford Jay · June 1, 2026 · Grant
    10.0K
  • Hoffman Koen · June 1, 2026 · Grant
    10.0K
  • Michael Holder · June 1, 2026 · Grant
    10.0K
  • McGarrity Michael · June 1, 2026 · Grant
    612.4K
  • McGarrity Michael · June 1, 2026 · Grant
    329.8K
  • Bellano John · June 1, 2026 · Grant
    217.0K
  • Bellano John · June 1, 2026 · Grant
    116.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.